DKK 300,000 to research into improved medication of patients with Alzheimer’s and Parkinson’s disease
Associate Professor and PhD Morten Schallburg Nielsen from the Department of Biomedicine at Aarhus University is receiving DKK 300,000 from the Riisfort Foundation. The grant will go towards funding research into the blood-brain barrier, and lead to the improved medication of patients with Alzheimer’s and Parkinson’s disease.
What is known as the blood-brain barrier protects the brain against foreign substances – and against medication intended to treat neurodegenerative brain diseases such as Alzheimer's and Parkinson's disease.
In his research, Morten Schallburg Nielsen searches for the transport receptors that are able to cross the blood-brain barrier unhindered. The goal is to be able to bind drugs to the most effective receptors so that these drugs can trick the blood-brain barrier that is blocking them and get into the brain.
The grant from the Riisfort Foundation gives Morten Schallburg Nielsen the opportunity to immerse himself in the receptors' transport mechanisms, which can in the long-term lead to improved medication of neurodegenerative brain diseases including Alzheimer's and Parkinson's disease.
Contact
Associate Professor, PhD Morten Schallburg Nielsen
Aarhus University, Department of Biomedicine
Mobile: (+45) 2899 2387
Email: mn@biomed.au.dk